Crux Pharmaceuticals was established in 2007. Crux Pharmaceuticals provides an end-to-end solution, from a business plan to a fully established company. 

We have managed an Oncology portfolio which was represented in the State Tender and marketed in the private sector. Sone of these Oncology products were first to market.

Crux Pharmaceutical was also responsible for initiating the registration of largest generic Vaccines portfolio in South Africa with the Medicines Control Council

We have Local and International Clients who are market leaders in their countries for whom we manage the registrations process.

The Crux team consists of experienced professionals with deep knowledge of the pharmaceutical industry in South Africa and a dedication to exceeding client expectations.

Ajit Mangalmurti, Founder and CEO

Ajit Mangalmurti has a MSc. (Pharmaceutical Affairs) degree from the University of Witwatersrand as well as a BCom.

He has worked in various senior postitions in the pharmacuetical field in several companies.